NM_001376.5(DYNC1H1):c.2032G>A (p.Glu678Lys) AND Charcot-Marie-Tooth disease axonal type 2O
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Oct 8, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002843202.3
Allele description [Variation Report for NM_001376.5(DYNC1H1):c.2032G>A (p.Glu678Lys)]
NM_001376.5(DYNC1H1):c.2032G>A (p.Glu678Lys)
Condition(s)
- Name:
- Charcot-Marie-Tooth disease axonal type 2O
- Synonyms:
- CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2O; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2O; Charcot-Marie-Tooth disease, axonal, type 20; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0013644; MedGen: C3280220; Orphanet: 284232; OMIM: 614228
-
1399209[uid] (1)
Taxonomy
-
Acknowledgements - Clinical effectiveness and cost-effectiveness of physiotherap...
Acknowledgements - Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)
-
Management of an episode of acute hepatic encephalopathy - Cirrhosis in Over 16s
Management of an episode of acute hepatic encephalopathy - Cirrhosis in Over 16s
-
Mus musculus zinc finger protein 313 (Zfp313), mRNA
Mus musculus zinc finger protein 313 (Zfp313), mRNAgi|27477064|ref|NM_030743.3|Nucleotide
-
SRX7544207 (1)
SRA
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024